Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Glucose Analysis Tubes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... to grow from a value of US$ 526 million in 2025 to US$ 796 million by 2032, reflecting a steady CAGR of 6.09% during the forecast period from 2023 to 2032. Market Insights Glucose analysis ... Read More
-
2025 Blood & AutoImmune Diseases Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the blood and blood-forming ... Read More
-
Thrombocytopenia - Global Clinical Trials Review, 2025
... to the clinical trials on Thrombocytopenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ... Read More
-
Aplastic Anemia - Global Clinical Trials Review, 2025
... line data relating to the clinical trials on Aplastic Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More
-
2025 Global: Hemophilia Treatment Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
2025 Global: Hemophilia Drugs Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
Anticoagulants
... 9.2% over the analysis period 2024-2030. NOACs, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis period. Growth in ... Read More
-
Anemia Drugs
... CAGR of 4.1% over the analysis period 2024-2030. Iron Deficiency Anemia, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the end of the ... Read More
-
Intravenous (IV) Iron Drugs
... 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Heparin-induced Thrombocytopenia - Market Insight, Epidemiology, and Market Forecast - 2034
... the initiation of heparin therapy. It is primarily caused by the formation of antibodies against platelet factor 4 (PF4) and heparin. The diagnosis of Heparin-induced thrombocytopenia is based on a combination of clinical assessment, laboratory ... Read More
-
Hemophilia Drugs
... CAGR of 5.5% over the analysis period 2024-2030. Hemophilia A Drugs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$21.3 Billion by the end of the ... Read More
-
Hemoglobinopathies
... 7.1% over the analysis period 2024-2030. Sickle Cell Disease Indication, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$795.0 Million by the end of the analysis ... Read More
-
Iron Deficiency Anemia Therapy
... 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Oral Iron Therapy, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$11.1 Billion by ... Read More
-
Rare Hematology
... CAGR of 4.9% over the analysis period 2024-2030. Plasma Derived Factors, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$18.2 Billion by the end of the ... Read More
-
Rare Hemophilia Factors
... at a CAGR of 5.6% over the analysis period 2024-2030. Fresh Frozen Plasma, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$246.9 Million by the end ... Read More
-
Desmopressin
... 5.6% over the analysis period 2024-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$866.1 Million by the end of the analysis period. Growth ... Read More
-
Thalassemia Treatment
... CAGR of 6.5% over the analysis period 2024-2030. Blood Transfusion, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$560.0 Million by the end of the analysis ... Read More
-
Bleeding Disorders Treatment
... at a CAGR of 5.0% over the analysis period 2024-2030. Hemophilia A Treatment, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$12.3 Billion by the end ... Read More
-
Bloodstream Infection Testing
... at a CAGR of 6.9% over the analysis period 2024-2030. Conventional Testing, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$12.7 Billion by the end of ... Read More
-
Sickle Cell Disease Treatment
... 2030, growing at a CAGR of 18.7% over the analysis period 2024-2030. Blood Transfusion, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$6.5 Billion by the ... Read More
-
Plasma Fractionation
... CAGR of 5.1% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.8 Billion by the end of the analysis period. ... Read More
-
Fanconi Anemia Drug Market, By Treatment Type (Hematopoietic Growth Factors, Gene Therapy, Stem Cell Transplantation, and Other Therapies), By Age Group (Pediatric Patients and Adult Patients), By Disease Stage (Early-stage Disease and Advanced-stage Disease), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... disorder that is marked by bone marrow failure, congenital defects, and an increased risk of developing cancer. Numerous organ systems are impacted by fanconi anemia. Fanconi anemia results from a defective gene that harms cells, ... Read More
-
Plasma Fractionation Market by Type of Company
... 9.2% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Type of Company In-house Manufacturers Contract Service Providers Scale of Operation Preclinical Clinical Commercial Type ... Read More
-
2025 Global Forecast for Hemophilia Treatment Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
Blood Disease Drugs Industry Forecasts - China Focus
... in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market ... Read More
Research Assistance
